The gut-brain axis: a major glucoregulatory player

被引:31
作者
Burcelin, R. [1 ,2 ]
机构
[1] Fac Med Toulouse, INSERM, U858, F-31073 Toulouse, France
[2] Univ Toulouse, UPS, Inst Med Mol Rangueil I2MR, IFR31, F-31432 Toulouse 4, France
关键词
Diabetes; Incretins; Autonomic nervous system; Review; GLUCAGON-LIKE PEPTIDE-1; ARTERIAL-BLOOD FLOW; GLUCOSE-UTILIZATION; FOOD-INTAKE; IN-VIVO; INSULIN SENSITIVITY; MUSCARINIC NERVES; CONSCIOUS DOGS; PORTAL-VEIN; HEART-RATE;
D O I
10.1016/S1262-3636(10)70468-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucose homeostasis corresponds to the overall physiological, cellular, and molecular mechanisms which tightly maintain the glycaemia between similar to 4.5 and similar to 6 mM. The resulting blood glucose concentration is the consequence of a balance between the mechanisms that ensure the entry and the output of glucose in the blood. A dynamic balance needs hence to be perfectly achieved in order to maintain a physiological glycaemic concentration. Specialized cells from the intestine continuously detect changes in glucose concentration and send signals to peripheral tissues and the brain through the vagus nerve. The molecular mechanisms involved in glucose detection have not been perfectly defined but could resemble those from the insulin-secreting beta cells. The brain then integrates the enteric and circulating endocrine signals to generate a new signal towards peripheral tissues such as the pancreas, liver, muscles, and blood vessels. This metabolic reflex is called anticipatory since it allows the peripheral tissues to prepare for the adequate handling of nutrients. Diabetes is associated with an impaired anticipatory reflex, which hampers the proper detection of nutrients and leads to hyperglycaemic episodes. Recently, GLP-1-based therapies have demonstrated the improvement of glucose detection and their efficacy on glycaemic control. Although not yet fully demonstrated, GLP-1-based therapies regulate glucose sensors, which leads to the glycaemic improvement. Certainly other molecular targets could be identified to further generate new therapeutic strategies. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S54 / S58
页数:5
相关论文
共 44 条
[1]   The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway [J].
Abbott, CR ;
Monteiro, M ;
Small, CJ ;
Sajedi, A ;
Smith, KL ;
Parkinson, JRC ;
Ghatei, MA ;
Bloom, SR .
BRAIN RESEARCH, 2005, 1044 (01) :127-131
[2]   CONVERGENCE OF HEPATO-PORTAL GLUCOSE-SENSITIVE AFFERENT SIGNALS TO GLUCOSE-SENSITIVE UNITS WITHIN THE NUCLEUS OF THE SOLITARY TRACT [J].
ADACHI, A ;
SHIMIZU, N ;
OOMURA, Y ;
KOBASHI, M .
NEUROSCIENCE LETTERS, 1984, 46 (02) :215-218
[3]   Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats [J].
Barragán, JM ;
Eng, J ;
Rodríguez, R ;
Blázquez, E .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (05) :E784-E791
[4]   Enteric glial cells and their role in gastrointestinal motor abnormalities: Introducing the neuro-gliopathies [J].
Bassotti, Gabrio ;
Villanacci, Vincenzo ;
Fisogni, Simona ;
Rossi, Elisa ;
Baronio, Paola ;
Clerici, Carlo ;
Maurer, Christoph A. ;
Cathomas, Gieri ;
Antonelli, Elisabetta .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (30) :4035-4041
[5]   Portal glucose infusion in the mouse induces hypoglycemia - Evidence that the hepatoportal glucose sensor stimulates glucose utilization [J].
Burcelin, R ;
Dolci, W ;
Thorens, B .
DIABETES, 2000, 49 (10) :1635-1642
[6]   Glucose sensing by the hepatoportal sensor is GLUT2-dependent - In vivo analysis in GLUT2-null mice [J].
Burcelin, R ;
Dolci, W ;
Thorens, B .
DIABETES, 2000, 49 (10) :1643-1648
[7]   The incretins: a link between nutrients and well-being [J].
Burcelin, R .
BRITISH JOURNAL OF NUTRITION, 2005, 93 :S147-S156
[8]   GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization [J].
Burcelin, R ;
Crivelli, V ;
Perrin, C ;
Da Costa, A ;
Mu, J ;
Kahn, BB ;
Birnbaum, MJ ;
Kahn, CR ;
Vollenweider, P ;
Thorens, B .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10) :1555-1562
[9]   Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor [J].
Burcelin, R ;
Da Costa, A ;
Drucker, D ;
Thorens, B .
DIABETES, 2001, 50 (08) :1720-1728
[10]   Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity [J].
Cabou, Cendrine ;
Campistron, Gerard ;
Marsollier, Nicolas ;
Leloup, Corinne ;
Cruciani-Guglielmacci, Celine ;
Penicaud, Luc ;
Drucker, Daniel J. ;
Magnan, Christophe ;
Burcelin, Remy .
DIABETES, 2008, 57 (10) :2577-2587